StockTipsArenaBeta

BUY Divi's Laboratories Limited — Kavita Jain, Arihant Capital Markets

BUYDivi's Laboratories Limited
Divi's Laboratories share price target & all analyst calls

byKavita Jain, Arihant Capital MarketsHorizon: NA (inferred Swing (≤2wk))11 Aug 2026via CNBC Awaaz.

Entry₹8,495Inferred
Target₹8,650
Total upside +1.82% (call closed)
Stop loss₹8,450-0.53% risk
Exit₹8,65012 Aug 2026, 9:15 am
Target hit+1.82%0.00%upside left
Follow Kavita Jain for new calls(44% target hit, 70 closed calls)Get alertsWatch DIVISLAB for new buy/sell callsGet alertsSee 1 active Swing call on DIVISLABSee 105 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 12 Aug 2026
5 supporting3 neutral0 opposing
Supports the BUY call (5)

2 advisors have active intraday BUY calls on this stock, all issued in the last 14 days

Advisor consensus · adjacent horizon·11 Aug · today

4 other SEBI-registered advisors have active swing BUY calls on this stock, all issued in the last 14 days

Advisor consensus · same horizon·11 Aug · today

Divi's Laboratories posts 65% PAT surge in Q1FY27 on strong revenue growth

NewsGoogle News·6 Aug · 5d ago

(opens in new tab)

Divi's Labs Q1 Results: Profit Jumps 65.5%, Revenue Up 28% - Key Numbers

NewsNdtv-Profit·1 Aug · 1w ago

(opens in new tab)

Divi’s Laboratories Q1 profit surges 66% to ₹902 crore, revenue rises 28%

NewsCnbc-Tv18·1 Aug · 1w ago

(opens in new tab)
Neutral / worth noting (3)

Divi’s Laboratories Posts Q1 FY27 Earnings Call Transcript for Investors

NewsGoogle News·6 Aug · 5d ago

(opens in new tab)

Divi's Laboratories Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.

NSE · Outcome of Board Meeting·1 Aug · 1w ago

(opens in new tab)

Q1 results today: Divi's Labs, Muthoot Finance, APL Apollo among over 30 companies set to announce Q1 earnings

NewsLivemint·1 Aug · 1w ago

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Divi's Laboratories

All analyst calls on Divi's Laboratories

More from Kavita Jain, Arihant Capital Markets

Every call and its outcome